How many drugs treat Perioperative hypertension?

Drug Landscape tracks 4 marketed treatments for Perioperative hypertension (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/perioperative-hypertension.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Perioperative hypertension — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Perioperative hypertension (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Perioperative hypertension, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Brevibloc In Plastic Container	ESMOLOL	Pfizer	beta-Adrenergic Blocker	Beta-1 adrenergic receptor	1986-01-01
Nitroglycerin	glyceryl trinitrate	Fougera	Nitrate Vasodilator [EPC]	guanylate cyclase	1981-01-01
Brevibloc	Brevibloc	AOP Orphan Pharmaceuticals AG		Beta-1 adrenergic receptor, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor
nitroglycerine	nitroglycerine	University Hospital, Ghent		Atrial natriuretic peptide receptor 1, Soluble guanylate cyclase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

AOP Orphan Pharmaceuticals AG · 1 drug in Perioperative hypertension
Fougera · 1 drug in Perioperative hypertension
Pfizer · 1 drug in Perioperative hypertension
University Hospital, Ghent · 1 drug in Perioperative hypertension

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Perioperative hypertension:

Cite this brief

Drug Landscape (2026). Perioperative hypertension — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/perioperative-hypertension. Accessed 2026-06-10.

Perioperative hypertension full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing